SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-18-000064
Filing Date
2018-06-21
Accepted
2018-06-20 18:56:36
Documents
5
Period of Report
2018-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjune2018offering.htm 8-K 40274
2 UNDERWRITING AGREEMENT kindred-underwritingagreem.htm EX-1.1 307521
3 TG OPINION troygouldopinion.htm EX-5.1 19364
4 PRESS RELEASE june2018offeringlaunchpres.htm EX-99.1 10265
5 PRESS RELEASE june2018offeringpricingpre.htm EX-99.2 10825
  Complete submission text file 0001561743-18-000064.txt   389411
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 18910503
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1